Shopping Cart
Remove All
Your shopping cart is currently empty
Gosuranemab
😃Good
Catalog No. T77028Cas No. 1788032-39-2
Alias IPN007, IPN 007, BMS-986168, BIIB092, BIIB 092
Gosuranemab (BIIB092) is a humanised monoclonal antibody targeting N-terminal tau, inhibiting the propagation and aggregation of pathological tau proteins for potential application in Alzheimer's disease.
Gosuranemab
Gosuranemab
😃Good
Purity: 95%
Catalog No. T77028Alias IPN007, IPN 007, BMS-986168, BIIB092, BIIB 092Cas No. 1788032-39-2
Gosuranemab (BIIB092) is a humanised monoclonal antibody targeting N-terminal tau, inhibiting the propagation and aggregation of pathological tau proteins for potential application in Alzheimer's disease.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $290 | - | In Stock | |
| 5 mg | $755 | - | In Stock | |
| 10 mg | $1,280 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:97.5% (SDS-PAGE); 95.2% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Gosuranemab (BIIB092) is a humanised monoclonal antibody targeting N-terminal tau, inhibiting the propagation and aggregation of pathological tau proteins for potential application in Alzheimer's disease. |
| In vitro | Pre-incubation of Gosuranemab with AD-tau significantly inhibited tau aggregation in mouse primary cortical neurons [2]. |
| In vivo | Gosuranemab reduces tau aggregation in the cerebrospinal fluid of transgenic mice, inhibits microglial activation, and thereby improves their cognitive dysfunction [2]. |
| Synonyms | IPN007, IPN 007, BMS-986168, BIIB092, BIIB 092 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | Tau |
| Molecular Weight | 144.93 kDa |
| Cas No. | 1788032-39-2 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG4 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Gosuranemab | purchase Gosuranemab | Gosuranemab cost | order Gosuranemab | Gosuranemab in vivo | Gosuranemab in vitro | Gosuranemab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.